AbbVie Inc. (ABBV) vs Applied Materials, Inc. (AMAT)
See how AbbVie Inc. and Applied Materials, Inc. differ across market data and performance, so you can decide which asset best fits your strategy.
$267.33
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full Page$531.87
NasdaqGS
Applied Materials Inc. is the world’s largest manufacturer of semiconductor wafer fabrication equipment, with a broad portfolio covering nearly every segment of the WFE ecosystem. The company holds a leading market share in deposition technologies, which involve adding new material layers to semiconductor wafers. Applied Materials has greater exposure to general-purpose logic chips produced by integrated device manufacturers and foundries. Its customer base includes some of the world’s largest chipmakers, such as TSMC, Intel, and Samsung.
View Full PageKey Metrics Comparison
AbbVie Inc.ABBV
Market Cap$472.408B
Price$267.33
24h Change+0.59%
24h Volume$1.55M
Employees57,000
Shares Outstanding1,768,169,012
Applied Materials, Inc.AMAT
Market Cap$422.089B
Price$531.87
24h Change-1.92%
24h Volume$2.08M
Employees36,400
Shares Outstanding793,609,867
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
ABBV
52.8%AMAT
47.2%Volume Share
Share of combined 24h volume
ABBV
42.6%AMAT
57.4%24h Performance
Price change over last 24 hours
ABBV
0.59%AMAT
-1.92%Price Comparison
AbbVie Inc.
Applied Materials, Inc.